Biolase, Inc. (BIOL): Price and Financial Metrics

Biolase, Inc. (BIOL)

Today's Latest Price: $0.29 USD

0.01 (2.27%)

Updated Nov 27 1:00pm

Add BIOL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

BIOL Stock Summary

  • BIOL's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 94.85% of US stocks.
  • Revenue growth over the past 12 months for Biolase Inc comes in at -39.89%, a number that bests only 8.04% of the US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for BIOL comes in at -64.54% -- higher than that of just 5.6% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Biolase Inc are OPTN, ZIXI, JAGX, GEVO, and KALA.
  • Visit BIOL's SEC page to see the company's official filings. To visit the company's web site, go to

BIOL Stock Price Chart Interactive Chart >

Price chart for BIOL

BIOL Price/Volume Stats

Current price $0.29 52-week high $0.96
Prev. close $0.29 52-week low $0.21
Day low $0.29 Volume 1,067,956
Day high $0.30 Avg. volume 3,939,320
50-day MA $0.29 Dividend yield N/A
200-day MA $0.42 Market Cap 27.25M

Biolase, Inc. (BIOL) Company Bio

BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company was founded in 1984 and is based in Irvine, California.

BIOL Latest News Stream

Event/Time News Detail
Loading, please wait...

BIOL Latest Social Stream

Loading social stream, please wait...

View Full BIOL Social Stream

Latest BIOL News From Around the Web

Below are the latest news stories about Biolase Inc that investors may wish to consider to help them evaluate BIOL as an investment opportunity.

BIOLASE Hosts Nearly 400 Dental Professionals During Webinar On Landmark Study On Lasers And Managing Periodontitis

FOOTHILL RANCH, Calif., Sept. 15, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it hosted nearly 400 dental professionals last Thursday evening during a panel discussion on the NEW Journal of Periodontology landmark study from…

PR Newswire | September 15, 2020

Global Dental Lasers Market: COVID-19 Business Continuity Plan | Evolving Opportunities with A.R.C. Laser GmbH and BIOLASE Inc. | Technavio

LONDON--(BUSINESS WIRE)-- #DentalLasersMarket--The Global Dental Lasers Market will grow by $ 190.10 mn during 2020-2024

Business Wire | September 15, 2020

BIOLASE to Highlight Progress and Recent Achievements at the Colliers & Co. Institutional Investor Conference

FOOTHILL RANCH, Calif., Sept. 3, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an…

PR Newswire | September 3, 2020

BIOLASE, Inc. (BIOL) CEO Todd Norbe on Q2 2020 Results - Earnings Call Transcript

BIOLASE, Inc. (BIOL) Q2 2020 Earnings Conference Call August 13, 2020 4:30 PM ET Company Participants Todd Kehrli - The EVC Group Todd Norbe - Chief Executive Officer John Beaver - Chief Financial Officer Conference Call Participants Kyle Bauser - Colliers Securities Bruce Jackson - Benchmark Company Ed Woo -...

SA Transcripts on Seeking Alpha | August 14, 2020

Biolase EPS beats by $0.05, beats on revenue

Biolase (BIOL): Q2 GAAP EPS of -$0.12 beats by $0.05.Revenue of $2.94M (-66.0% Y/Y) beats by $0.85M.Shares +1%.Press Release...

Seeking Alpha | August 13, 2020

Read More 'BIOL' Stories Here

BIOL Price Returns

1-mo 5.80%
3-mo -8.66%
6-mo -27.48%
1-year -50.00%
3-year -89.26%
5-year -93.56%
YTD -47.53%
2019 -44.17%
2018 -53.95%
2017 -69.29%
2016 66.67%
2015 -68.06%

Continue Researching BIOL

Want to see what other sources are saying about Biolase Inc's financials and stock price? Try the links below:

Biolase Inc (BIOL) Stock Price | Nasdaq
Biolase Inc (BIOL) Stock Quote, History and News - Yahoo Finance
Biolase Inc (BIOL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9197 seconds.